Protalix BioTherapeutics Inc - Articles and news items

Pfizer logo

Pfizer and Protalix BioTherapeutics announce FDA approval of pediatric Indication for ELELYSO™ (taliglucerase alfa) for injection

Industry news / 29 August 2014 / Pfizer

…for intravenous use for the treatment of type 1 Gaucher disease.

Pfizer logo

 

The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...
+